Use access key #2 to skip to page content.
$6.89 -0.11 (-1.57%)
11/21/2008 11:51 AM

Momenta Pharmaceuticals, Inc. (MNTA)

CAPS Rating:
****

A biotechnology company specializing in the detailed structural analysis of complex mixture drugs of the development of generic or biosimilar versions of complex drug products as well as to the discovery and development of novel drugs.

View All Commentary (MNTA)

Recs

0

Avatar ToogleBH (29.67) Submitted: 11/26/06 1:11 AM : Outperform Start Price: $17.34 MNTA Score: -14.33

Biotech. Developing several generic drugs that have proven difficult to reproduce.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links